Diversified holding company Digirad Corporation (NASDAQ: DRAD) has confirmed it will sell DMS health for $18.75 million.
The California-based company said that it has agreed to a stock purchase agreement with the proceeds being used to pay down its debt and finance its growth strategy.
Digirad transformed into a diversified holding company through its acquisition of ATRM Holdings in October 2019.
WELCOME BONUS - Free Share Bundle When You Invest £50!
Open a UK Investment Account: Shares, ISAs, Managed Portfolio
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
IG
View Offers
Empfohlener Broker
Multi Asset Platform
DMS Health is the mobile healthcare business unit of Digirad’s healthcare division and provides contract diagnostic imaging and healthcare expertise via a mobile service. The company generated a revenue of $41.3 million in 2019.
“The divestiture of DMS Health will allow us to streamline our portfolio of healthcare services by focusing our efforts on selling and servicing our Digirad branded solid-state imaging cameras and providing on-site imaging services to hospitals and physicians all over the country,” commented Matt Molchan, Dad’s CEO.
Shares of Digirad have surged premarket on Wednesday, up 25.05% at $3.17 after closing Tuesday’s session at $2.53.
PEOPLE WHO READ THIS ALSO VIEWED:
- Best AIM shares to buy right now
- Trade stocks with eToro
- Best Gaming Stocks to buy right now